Literature DB >> 20090777

NHR4 domain mutations of ETO are probably very infrequent in AML1-ETO positive myeloid leukemia cells.

B Hackanson, M Abdelkarim, J H Jansen, M Lübbert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20090777     DOI: 10.1038/leu.2009.291

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

Review 1.  RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making.

Authors:  James K Mangan; Nancy A Speck
Journal:  Crit Rev Oncog       Date:  2011

2.  Supraphysiologic levels of the AML1-ETO isoform AE9a are essential for transformation.

Authors:  Kevin A Link; Shan Lin; Mahesh Shrestha; Melissa Bowman; Mark Wunderlich; Clara D Bloomfield; Gang Huang; James C Mulloy
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-25       Impact factor: 11.205

Review 3.  RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.

Authors:  Kentson Lam; Dong-Er Zhang
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.